click on the title to access to the PubMed abstract

2020

• Alberti P, Canta A, Chiorazzi A, Fumagalli G, Meregalli C, Monza L, Pozzi E, Ballarini E, Rodriguez-Menendez V, Oggioni N, Sancini G, Marmiroli P, Cavaletti G. Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity. Neuropharmacology 2020 Mar 1;164:107905. doi: 10.1016/j.neuropharm.2019.107905
• Bruna J, Alberti P, Calls-Cobos A, Caillaud M, Damaj MI, Navarro X. Methods for in vivo studies in rodents of chemotherapy induced peripheral neuropathy. Exp Neurol. 2020 Mar;325:113154. doi: 10.1016/j.expneurol.2019.113154. Epub 2019 Dec 15. PMID: 31837318.
• Doneddu PE, Bianchi E, Cocito D, Manganelli F, Fazio R, Filosto M, Mazzeo A, Cosentino G, Cortese A, Jann S, Clerici AM, Antonini G, Siciliano G, Luigetti M, Marfia GA, Briani C, Lauria G, Rosso T, Cavaletti G, Carpo M, Benedetti L, Beghi E, Liberatore G, Santoro L, Peci E, Tronci S, Cotti Piccinelli S, Toscano A, Piccolo L, Verrengia EP, Leonardi L, Schirinzi E, Mataluni G, Ruiz M, Dacci P, Nobile-Orazio E; Italian CIDP Database Study Group. Risk factors for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): antecedent events, lifestyle and dietary habits. Data from the Italian CIDP Database. Eur J Neurol. 2020 Jan;27(1):136-143. doi: 10.1111/ene.14044. Epub 2019 Aug 9. PubMed PMID: 31325350.
• Fumagalli G, Monfrini M, Donzelli E, Rodriguez-Menendez V, Bonandrini B, Figliuzzi M, Remuzzi A, D’Amico G, Cavaletti G, Scuteri A. Protective Effect of Human Mesenchymal Stem Cells on the Survival of Pancreatic Islets. Int J Stem Cells. 2019 Dec 31. doi: 10.15283/ijsc19094. [Epub ahead of print]
• Verboon C, van den Berg B, Cornblath DR, Venema E, Gorson KC, Lunn MP, Lingsma H, Van den Bergh P, Harbo T, Bateman K, Pereon Y, Sindrup SH, Kusunoki S, Miller J, Islam Z, Hartung HP, Chavada G, Jacobs BC, Hughes RAC, van Doorn PA; IGOS Consortium. Original research: Second IVIg course in Guillain-Barré syndrome with poor prognosis: the non-randomised ISID study. J Neurol Neurosurg Psychiatry. 2020 Feb;91(2):113-121. doi: 10.1136/jnnp-2019-321496. Epub 2019 Oct 5. PubMed PMID: 31586949.

2019

• Alberti P, Cavaletti G, Cornblath DR. Toxic neuropathies: Chemotherapy Induced Peripheral Neurotoxicity. Curr Opin Neurol. 2019 Oct;32(5):676-683. doi: 10.1097/WCO.0000000000000724. PubMed PMID: 31306214
• Alberti P. Platinum-drugs induced peripheral neurotoxicity: clinical course and preclinical evidence. Expert Opin Drug Metab Toxicol. 2019 Jun;15(6):487-497. doi: 10.1080/17425255.2019.1622679. PubMed PMID: 31116618
• Argyriou AA, Antonacopoulou AG, Alberti P, Briani C, Bruna J, Velasco R, Anastopoulou GG, Park SB, Cavaletti G, Kalofonos HP. Liability of the voltage-gated potassium channel KCNN3 repeat polymorphism to acute oxaliplatin-induced peripheral neurotoxicity. J Peripher Nerv Syst. 2019 Dec;24(4):298-303. doi: 10.1111/jns.12347. Epub 2019 Oct 16. PubMed [citation] PMID: 31486252
• Argyriou AA, Cavaletti G, Park SB; Toxic Neuropathy Consortium (TNC). The Toxic Neuropathy Consortium of the Peripheral Nerve Society. J Peripher Nerv Syst. 2019 Oct;24 Suppl 2:S4-S5. doi: 10.1111/jns.12331. PubMed PMID: 31647150.
• Argyriou AA, Park SB, Bruna J, Cavaletti G. Voltage-gated sodium channel dysfunction and the search for other satellite channels in relation to acute oxaliplatin-induced peripheral neurotoxicity. J Peripher Nerv Syst. 2019 Dec;24(4):360-361. doi: 10.1111/jns.12354. Epub 2019 Nov 7. PubMed PMID: 31696990.
• Argyriou AA, Park SB, Islam B, Tamburin S, Velasco R, Alberti P, Bruna J, Psimaras D, Cavaletti G, Cornblath DR; Toxic Neuropathy Consortium (TNC). Neurophysiological, nerve imaging and other techniques to assess chemotherapy-induced peripheral neurotoxicity in the clinical and research settings. J Neurol Neurosurg Psychiatry. 2019 Dec;90(12):1361-1369. doi: 10.1136/jnnp-2019-320969. Review. PubMed PMID: 31256000
• Arosio A, Cristofani R, Pansarasa O, Crippa V, Riva C, Sirtori R, Rodriguez-Menendez V, Riva N, Gerardi F, Lunetta C, Cereda C, Poletti A, Ferrarese C, Tremolizzo L, Sala G. HSC70 expression is reduced in lymphomonocytes of sporadic ALS patients and contributes to TDP-43 accumulation. Amyotroph Lateral Scler Frontotemporal Degener. 2019 Oct 30:1-12. doi: 10.1080/21678421.2019.1672749.
• Calls A*, Carozzi V*, Navarro X, Monza L, Bruna J. Pathogenesis of platinum-induced peripheral neurotoxicity: Insights from preclinical studies  Exp Neurol. 2019 Dec 19;325:113141. doi: 10.1016/j.expneurol.2019.113141. *equally contributed
• Cavaletti G, Alberti P, Argyriou AA, Lustberg M, Staff NP, Tamburin S; Toxic Neuropathy Consortium of the Peripheral Nerve Society. Chemotherapy-induced peripheral neurotoxicity: A multifaceted, still unsolved issue. J Peripher Nerv Syst. 2019 Oct;24 Suppl 2:S6-S12. doi: 10.1111/jns.12337. Review. PubMed [citation] PMID: 31647155
• Cavaletti G, Cornblath DR, Merkies ISJ, Postma TJ, Rossi E, Alberti P, Bruna J, Argyriou AA, Briani C, Velasco R, Kalofonos HP, Psimaras D, Ricard D, Pace A, Faber CG, Lalisang RI, Brandsma D, Koeppen S, Kerrigan S, Schenone A, Grisold W,  Mazzeo A, et al. Patients’ and physicians’ interpretation of chemotherapy-induced peripheral neurotoxicity. J Peripher Nerv Syst. 2019 Mar;24(1):111-119. doi: 10.1111/jns.12306. Epub 2019 Feb 8. PubMed PMID: 30672664
• Cavaletti G, Cornblath DR. Chemotherapy-induced peripheral neurotoxicity: Facts, needs and future directions. J Peripher Nerv Syst. 2019 Oct;24 Suppl 2:S86-S87. doi: 10.1111/jns.12332. PubMed PMID: 31647156.
• Di Lorenzo F, Alberti P, Pavolucci L, Pietrafusa N, Iodice F. Introduction to the Italian section for young neurologists. Neurol Sci. 2019 Nov;40(11):2423-2424. doi: 10.1007/s10072-019-03967-4. Epub 2019 Jun 14. No abstract available. PubMed PMID: 31201599
• Doneddu PE, Cocito D, Manganelli F, Fazio R, Briani C, Filosto M, Benedetti L, Mazzeo A, Marfia GA, Cortese A, Fierro B, Jann S, Beghi E, Clerici AM, Carpo M, Schenone A, Luigetti M, Lauria G, Antonini G, Rosso T, Siciliano G, Cavaletti  G, Liberatore G, Santoro L, Peci E, Tronci S, Ruiz M, Cotti Piccinelli S, Toscano A, Mataluni G, Piccolo L, Cosentino G, Sabatelli M, Nobile-Orazio E; Italian CIDP Database study group. Atypical CIDP: diagnostic criteria, progression and treatment response. Data from the Italian CIDP Database. J Neurol Neurosurg Psychiatry. 2019 Feb;90(2):125-132. doi: 10.1136/jnnp-2018-318714. PubMed PMID: 30297520.
• Dorsey SG, Kleckner IR, Barton D, Mustian K, O’Mara A, St Germain D, Cavaletti G, Danhauer SC, Hershman D, Hohmann AG, Hoke A, Hopkins JO, Kelly KP, Loprinzi CL, McLeod HL, Mohile S, Paice J, Rowland JH, Salvemini D, Segal RA, Lavoie Smith E, McCaskill Stevens W, Janelsins MC. NCI Clinical Trials Planning Meeting for prevention and treatment of chemotherapy-induced peripheral neuropathy. J Natl Cancer Inst. 2019 Jun 1;111(6):531-537. doi: 10.1093/jnci/djz011. PMID: 30715378.
• Farina F, Lonati E, Milani C, Massimino L, Ballarini E, Donzelli E, Crippa L, Marmiroli P, Botto L, Corsetto PA, Sancini G, Bulbarelli A, Palestini P.In Vivo Comparative Study on Acute and Sub-acute Biological Effects Induced by Ultrafine Particles of Different Anthropogenic Sources in BALB/c Mice. Int J Mol Sci. 2019 Jun 8;20(11). pii: E2805. doi: 10.3390/ijms20112805.
• Formicola B, D’Aloia A, Dal Magro Ra, Stucchi S, Rigolio R, Ceriani M, Re F. Differential Exchange of Multifunctional Liposomes Between Glioblastoma Cells and Healthy Astrocytes via Tunneling Nanotubes. Frontiers in Bioengineering and Biotechnology 2019. 7:403 DOI=10.3389/fbioe.2019.00403
• Gewandter JS, Gibbons CH, Campagnolo M, Lee J, Chaudari J, Ward N, Burke L, Cavaletti G, Herrmann DN, McArthur JC, Russell JW, Smith AG, Smith SM, Turk DC, Dworkin RH, Freeman R. Clinician-rated measures for distal symmetrical axonal polyneuropathy: ACTTION systematic review. Neurology. 2019 Aug 20;93(8):346-360. doi: 10.1212/WNL.0000000000007974. Epub 2019 Jul 18. Review. PubMed PMID: 31320471.
• Hucke A, Rinschen MM, Bauer OB, Sperling M, Karst U, Köppen C, Sommer K, Schröter R, Ceresa C, Chiorazzi A, Canta A, Semperboni S, Marmiroli P, Cavaletti G, Schlatt S, Schlatter E, Pavenstädt H, Heitplatz B, Van Marck V, Sparreboom A, Barz V, Knief A, Deuster D, Zehnhoff-Dinnesen AA, Ciarimboli G.An integrative approach to cisplatin chronic toxicities in mice reveals importance of organic cation-transporter-dependent protein networks for renoprotection. Arch Toxicol. 2019 Oct;93(10):2835-2848. doi: 10.1007/s00204-019-02557-9.
• Islam B, Lustberg M, Staff NP, Kolb N, Alberti P, Argyriou AA. Vinca alkaloids, thalidomide and eribulin-induced peripheral neurotoxicity: From pathogenesis to treatment. J Peripher Nerv Syst. 2019 Oct;24 Suppl 2:S63-S73. doi: 10.1111/jns.12334. Review. PubMed [citation] PMID: 31647152
• Lessans S, Lassiter CB, Carozzi V, Heindel P, Semperboni S, Oggioni N, Chiorazzi A, Thompson C, Wagner M, Holden J, Rahn E, Sweatt JD, Cavaletti G, Renn CL, Dorsey SG. Global Transcriptomic Profile of Dorsal Root Ganglion and Physiological Correlates of Cisplatin-Induced Peripheral Neuropathy.  Nurs Res. 2019 Mar/Apr;68(2):145-155. doi: 10.1097/NNR.0000000000000338. PubMed PMID: 30586060.
• Malacrida A, Cavalloro V, Martino E, Cassetti A, Nicolini G, Rigolio R, Cavaletti G, Mannucci B, Vasile F, Giacomo MD, Collina S, Miloso M. Anti-Multiple Myeloma Potential of Secondary Metabolites from Hibiscus sabdariffa. Molecules 2019 Jul 9;24(13):2500. doi: 10.3390/molecules24132500. PMID: 31323932; PMCID: PMC6651714.Malacrida A, Meregalli C, Rodriguez-Menendez V, Nicolini G. Chemotherapy-Induced Peripheral Neuropathy and Changes in Cytoskeleton. Int J Mol Sci. 2019 May 9;20(9). pii: E2287. doi: 10.3390/ijms20092287. Review.
• Malacrida A, Rivara M, Di Domizio A, Cislaghi G, Miloso M, Zuliani V, Nicolini G. (2019) 3D proteome-wide scale screening and activity evaluation of a new ALKBH5 inhibitor in U87 glioblastoma cell line. Bioorg Med Chem. 2019 Dec 30:115300. doi: 10.1016/j.bmc.2019.115300.
• Mariotto S, Tecchio C, Sorio M, Bertolasi L, Turatti M, Tozzi MC, Benedetti F, Cavaletti G, Monaco S, Ferrari S. Clinical and neurophysiological serial assessments of brentuximab vedotin-associated peripheral neuropathy. Leuk Lymphoma. 2019 Nov;60(11):2806-2809. doi: 10.1080/10428194.2019.1605068. PubMed PMID: 31057013.
• Melcangi RC, Casarini L, Marino M, Santi D, Sperduti S, Giatti S, Diviccaro S, Grimoldi M, Caruso D, Cavaletti G, Simoni M. Altered methylation pattern of the SRD5A2 gene in the cerebrospinal fluid of post-finasteride patients: a pilot study. Endocr Connect. 2019 Aug 1;8(8):1118-1125. doi: 10.1530/EC-19-0199. PubMed PMID: 31272082; PubMed Central PMCID: PMC6652249.
• Murtaj V, Belloli S, Di Grigoli G, Pannese M, Ballarini E, Rodriguez-Menendez V, Marmiroli P, Cappelli A, Masiello V, Monterisi C, Bellelli G, Panina-Bordignon P, Moresco RM.Age and Sex Influence the Neuro-inflammatory Response to a Peripheral Acute LPS Challenge. Front Aging Neurosci. 2019 Nov 5;11:299. doi: 10.3389/fnagi.2019.00299.
• Park SB, Alberti P, Kolb NA, Gewandter JS, Schenone A, Argyriou AA. Overview and critical revision of clinical assessment tools in chemotherapy-induced peripheral neurotoxicity. J Peripher Nerv Syst. 2019 Oct;24 Suppl 2:S13-S25. doi: 10.1111/jns.12333. Review. PubMed PMID: 31647154
• Potenzieri A, Riva B, Rigolio R, Chiorazzi A, Pozzi E, Ballarini E, Cavaletti G, Genazzani AA. Oxaliplatin-induced neuropathy occurs through impairment of haemoglobin proton buffering and is reversed by carbonic anhydrase inhibitors. Pain. 2019 Oct 17. doi: 10.1097/j.pain.0000000000001722.
• Scarpazza C, Signori A, Prosperini L, Sormani MP, Cosottini M, Capra R, Gerevini S; Italian PML Group. Early diagnosis of progressive multifocal leucoencephalopathy: longitudinal lesion evolution. J Neurol Neurosurg Psychiatry. 2019 Mar;90(3):261-267. doi: 10.1136/jnnp-2018-319208. PubMed PMID: 30389778.
• Smith EML, Banerjee T, Yang JJ, Bridges CM, Alberti P, Sloan JA, Loprinzi C. Psychometric Testing of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Chemotherapy-Induced Peripheral Neuropathy 20-Item Scale Using Pooled Chemotherapy-Induced Peripheral Neuropathy Outcome Measures Standardization and Alliance for Clinical Trials in Oncology A151408 Study Data. Cancer Nurs. 2019 May/Jun;42(3):179-189. doi: 10.1097/NCC.0000000000000596. PubMed PMID: 29649081, PMCID: PMC6185825
• Staff NP, Cavaletti G, Islam B, Lustberg M, Psimaras D, Tamburin S. Platinum-induced peripheral neurotoxicity: From pathogenesis to treatment. J Peripher Nerv Syst. 2019 Oct;24 Suppl 2:S26-S39. doi: 10.1111/jns.12335. Review. PubMed PMID: 31647151; PubMed Central PMCID: PMC6818741.
• Tamburin S, Park SB, Alberti P, Demichelis C, Schenone A, Argyriou AA. Taxane and epothilone-induced peripheral neurotoxicity: From pathogenesis to treatment. J Peripher Nerv Syst. 2019 Oct;24 Suppl 2:S40-S51. doi: 10.1111/jns.12336. Review.  PubMed PMID: 31647157
• Tesei A, Cortesi M, Pignatta S, Arienti C, Dondio GM, Bigogno C, Malacrida A, Miloso M, Meregalli C, Chiorazzi A, Carozzi V, Cavaletti G, Rui M, Marra A, Rossi D, Collina S. (2019)  Anti-tumor Efficacy Assessment of the Sigma Receptor Pan Modulator RC-106. A Promising Therapeutic Tool for Pancreatic Cancer. Front Pharmacol. 14; 10:490. doi: 10.3389/fphar.2019.00490. eCollection 2019.
• Trojano M, Bergamaschi R, Amato MP, Comi G, Ghezzi A, Lepore V, Marrosu MG, Mosconi P, Patti F, Ponzio M, Zaratin P, Battaglia MA; Italian Multiple Sclerosis Register Centers Group. The Italian multiple sclerosis register. Neurol Sci. 2019 Jan;40(1):155-165. doi: 10.1007/s10072-018-3610-0. Epub 2018 Nov 13. Erratum in: Neurol Sci. 2019 Apr;40(4):907. PubMed PMID: 30426289; PubMed Central PMCID: PMC6329744.
• Velasco R, Alberti P, Bruna J, Psimaras D, Argyriou AA. Bortezomib and other proteosome inhibitors-induced peripheral neurotoxicity: From pathogenesis to treatment. J Peripher Nerv Syst. 2019 Oct;24 Suppl 2:S52-S62. doi: 10.1111/jns.12338. Review. PubMed PMID: 31647153
• Verboon C, Doets AY, Galassi G, Davidson A, Waheed W, Péréon Y, Shahrizaila N, Kusunoki S, Lehmann HC, Harbo T, Monges S, Van den Bergh P, Willison HJ, Cornblath DR, Jacobs BC; IGOS Consortium. Current treatment practice of Guillain-Barré syndrome. Neurology. 2019 Jul 2;93(1):e59-e76. doi: 10.1212/WNL.0000000000007719. Epub 2019 Jun 7. PubMed PMID: 31175208.

2018

• Chiorazzi A, Wozniak KM, Raisb R, Wu Y, Gadiano AG, Farah MH, Liu Y, Canta A, Alberti P, Rodriguez-Menendez V, Meregalli C, Fumagalli G, Monza L, Pozzi E, Vornov JJ, Polydefkis M, Pietra C, Slusher BS, Cavaletti G. Ghrelin Agonist HM01 Attenuates Chemotherapy-Induced Neurotoxicity in Rodent Models. Eur J Pharmacol. 2018 Dec 5;840:89-103. doi: 10.1016/j.ejphar.2018.09.029. Epub 2018 Sep 27.
• Scarpazza, C., Signori, A., Prosperini, L., Sormani, M.P., Cosottini, M., Capra, R., Gerevini, S., Altieri, M., Amato, M.P., Artusi, C.A., Bandini, F., Barcella, V., Bertolotto, A., Morra, V.B., Capobianco, M., Cavaletti, G., Cavalla, P., Centonze, D., Chiusole, M., Clerico, M., Cordioli, C., D’Aleo, G., De Luca, G., De Riz, M., De Rossi, N., Deotto, L., Durelli, L., Falcini, M., Ferrante, C., Ferrari, E., Fusco, M.L., Gasperini, C., Ghezzi, A., Grimaldi, L., Guidotti, M., Laroni, A., Lugaresi, A., Moiola, L., Naldi, P., Pane, C., Palmeri, B., Perrone, P., Pizzorno, M., Pozzilli, C., Rezzonico, M., Rottoli, M.R., Rovaris, M., Salemi, G., Salvetti, M., Santuccio, G., Scarpini, E., Sessa, E., Solaro, C., Stenta, G., Tabiadon, G., Tortorella, C., Trojano, M., Valentino, P., Rottoli, M.R., the Italian PML Group. Early diagnosis of progressive multifocal leucoencephalopathy: Longitudinal lesion evolution. J Neurol Neurosurg Psychiatry. 2018 Nov 2. pii: jnnp-2018-319208. doi: 10.1136/jnnp-2018-319208. [Epub ahead of print]
• Rui M, Rossino G, Coniglio S, Monteleone S, Scuteri A., Malacrida A, Rossi D, Catenacci L, Sorrenti M, Paolillo M, Curti D, Venturini L, Schepmann D, Wünsch B,Liedl KR, Cavaletti G, Pace V, Urban E, Collina S. Identification of dual Sigma1 receptor modulators/acetylcholinesterase inhibitors with antioxidant and neurotrophic properties, as neuroprotective agents. Eur J Med Chem. 2018 Oct 5;158:353-370. doi: 10.1016/j.ejmech.2018.09.010.
• Riva, B., Dionisi, M., Potenzieri, A., Chiorazzi, A., Cordero-Sanchez, C., Rigolio, R., Carozzi, V.A., Lim, D., Cavaletti, G., Marmiroli, P., Distasi, C., Genazzani, A.A. Oxaliplatin induces pH acidification in dorsal root ganglia neurons. Sci Rep. 2018 Oct 10;8(1):15084. doi: 10.1038/s41598-018-33508-6.
• Doets, A.Y., Verboon, C., Van Den Berg, B., Harbo, T., Cornblath, D.R., Willison, H.J., Islam, Z., Attarian, S., Barroso, F.A., Bateman, K., Benedetti, L., Van Den Bergh, P., Casasnovas, C., Cavaletti, G., Chavada, G., Claeys, K.G., Dardiotis, E., Davidson, A., Van Doorn, P.A., Feasby, T.E., Galassi, G., Gorson, K.C., Hartung, H.-P., Hsieh, S.-T., Hughes, R.A.C., Illa, I., Islam, B., Kusunoki, S., Kuwabara, S., Lehmann, H.C., Miller, J.A.L., Mohammad, Q.D., Monges, S., Nobile Orazio, E., Pardo, J., Pereon, Y., Rinaldi, S., Querol, L., Reddel, S.W., Reisin, R.C., Shahrizaila, N., Sindrup, S.H., Waqar, W., Jacobs, B.C. Regional variation of Guillain-Barré syndrome. Brain. 2018 Oct 1;141(10):2866-2877. doi: 10.1093/brain/awy232.
• Ambrosini, A., Calabrese, D., Avato, F.M., Catania, F., Cavaletti, G., Pera, M.C., Toscano, A., Vita, G., Monaco, L., Pareyson, D. The Italian neuromuscular registry: A coordinated platform where patient organizations and clinicians collaborate for data collection and multiple usage. Orphanet J Rare Dis. 2018 Oct 4;13(1):176. doi: 10.1186/s13023-018-0918-z.
• Scuteri A., Monfrini M. Mesenchymal Stem Cells as New Therapeutic Approach for Diabetes and Pancreatic Disorders. Int J Mol Sci. 2018 Sep 16;19(9). pii: E2783. doi: 10.3390/ijms19092783.
• Meregalli C, Fumagalli G, Alberti P, Canta A, Carozzi VA, Chiorazzi A, Monza L, Pozzi E, Sandelius Å, Blennow K, Zetterberg H, Marmiroli P, Cavaletti G. Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy. Exp Neurol. 2018 Sep;307:129-132.
• Alberti P, Rossi E, Argyriou AA, Kalofonos HP, Briani C, Cacciavillani M, Campagnolo M, Bruna J, Velasco R, Cazzaniga ME, Cortinovis D, Valsecchi MG, Cavaletti G. Risk stratification of oxaliplatin induced peripheral neurotoxicity applying electrophysiological testing of dorsal sural nerve. Support Care Cancer. 2018 Sep;26(9):3143-3151. doi: 10.1007/s00520-018-4170-9. Epub 2018 Mar 29.
• Meregalli C, Marjanovic I, Scali C, Monza L, Spinoni N, Galliani C, Brivio R, Chiorazzi A, Ballarini E, Rodriguez-Menendez V, Carozzi VA, Alberti P, Fumagalli G, Pozzi E, Canta A, Quartu M, Briani C, Marmiroli P, Cavaletti G. High-Dose Intravenous Immunoglobulins Reduce Nerve Macrophages Infiltration and the Severity of Bortezomib-Induced Peripheral Neurotoxicity in Rats. J Neuroinflammation. 2018 Aug 21;15(1):232.
• Gewandter, J.S., Brell, J., Cavaletti, G., Dougherty, P.M., Evans, S., Howie, L., McDermott, M.P., O’Mara, A., Gordon Smith, A., Dastros-Pitei, D., Gauthier, L.R., Haroutounian, S., Jarpe, M., Katz, N.P., Loprinzi, C., Richardson, P., Lavoie-Smith, E.M., Wen, P.Y., Turk, D.C., Dworkin, R.H., Freeman, R. Trial designs for chemotherapy-induced peripheral neuropathy prevention. Neurology. 2018 Aug 28;91(9):403-413. doi: 10.1212/WNL.0000000000006083. Epub 2018 Jul 27.
• Ceresa C, Nicolini G, Semperboni S, Gandin V, Monfrini M, Avezza F, Alberti P, Bravin A, Pellei M, Santini C, Cavaletti G. Evaluation of the Profile and Mechanism of Neurotoxicity of Water-Soluble [Cu(P)4]PF6 and [Au(P)4]PF6 (P = thp or PTA) Anticancer Complexes. Neurotox Res. 2018 Jul;34(1):93-108. doi: 10.1007/s12640-018-9864-8. Epub 2018 Jan 17.
• van Leeuwen M, Husson O, Alberti P, Arraras JI, Chinot OL, Costantini A, Darlington AS, Dirven L, Eichler M, Hammerlid EB, Holzner B, Johnson CD, Kontogianni M, Kjær TK, Morag O, Nolte S, Nordin A, Pace A, Pinto M, Polz K, Ramage J, Reijneveld JC, Serpentini S, Tomaszewski KA, Vassiliou V, Verdonck-de Leeuw IM, Vistad I, Young TE, Aaronson NK, van de Poll-Franse LV. Understanding the quality of life (QOL) issues in survivors of cancer: towards the development of an EORTC QOL cancer survivorship questionnaire. Health Qual Life Outcomes. 2018 Jun 4;16(1):114. doi: 10.1186/s12955-018-0920-0.
• Smith EML, Banerjee T, Yang JJ, Bridges CM, Alberti P, Sloan JA, Loprinzi C. Psychometric Testing of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Chemotherapy-Induced Peripheral Neuropathy 20-Item Scale Using Pooled Chemotherapy-Induced Peripheral Neuropathy Outcome Measures Standardization and Alliance for Clinical Trials in Oncology A151408 Study Data. Cancer Nurs. 2018 Apr 12. doi: 10.1097/NCC.0000000000000596.
• Van Helleputte, L., Kater, M., Cook, D.P., Eykens, C., Rossaert, E., Haeck, W., Jaspers, T., Geens, N., Vanden Berghe, P., Gysemans, C., Mathieu, C., Robberecht, W., Van Damme, P., Cavaletti, G., Jarpe, M., Van Den Bosch, L. Inhibition of histone deacetylase 6 (HDAC6) protects against vincristine-induced peripheral neuropathies and inhibits tumor growth. Neurobiol Dis. 2018 Mar;111:59-69. doi: 10.1016/j.nbd.2017.11.011. Epub 2017 Nov 29.
• Cavaletti, G., Marmiroli, P. Pharmacotherapy options for managing chemotherapy-induced peripheral neurotoxicity. Expert Opin Pharmacother. 2018 Feb;19(2):113-121. doi: 10.1080/14656566.2017.1415326. Epub 2017 Dec 15.
• Wozniak KM, Vornov JJ, Wu Y, Liu Y, Carozzi VA, Rodriguez-Menendez V, Ballarini E, Alberti P, Pozzi E, Semperboni S, Cook BM, Littlefield BA, Nomoto K, Condon K, Eckley S, DesJardins C, Wilson L, Jordan MA, Feinstein SC, Cavaletti G, Polydefkis M, Slusher BS. Peripheral Neuropathy Induced by Microtubule-Targeted Chemotherapies: Insights into Acute Injury and Long-term Recovery. Cancer Res. 2018 Feb 1;78(3):817-829. doi: 10.1158/0008-5472.CAN-17-1467. Epub 2017 Nov 30.
• Dal Magro R, Albertini B, Beretta S, Rigolio R, Donzelli E, Chiorazzi A, Ricci M, Blasi P, Sancini G. Artificial apolipoprotein corona enables nanoparticle brain targeting. Nanomedicine. 2018 Feb 21;14(2):429-438. doi: 10.1016/j.nano.2017.11.008.
• Leblanc AF, Sprowl JA, Alberti P, Chiorazzi A, Arnold WD, Gibson AA, Hong KW, Pioso MS, Chen M, Huang KM, Chodisetty V, Costa O, Florea T, de Bruijn P, Mathijssen RH, Reinbolt RE, Lustberg MB, Sucheston-Campbell LE, Cavaletti G, Sparreboom A, Hu S.OATP1B2 deficiency protects against paclitaxel-induced neurotoxicity. J Clin Invest. 2018 Feb 1;128(2):816-825. doi: 10.1172/JCI96160. Epub 2018 Jan 16.
• Bruna J, Videla S, Argyriou AA, Velasco R, Villoria J, Santos C, Nadal C, Cavaletti G, Alberti P, Briani C, Kalofonos HP, Cortinovis D, Sust M, Vaqué A, Klein T, Plata-Salamán C. Efficacy of a Novel Sigma-1 Receptor Antagonist for Oxaliplatin-Induced Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Clinical Trial. Neurotherapeutics. 2018 Jan;15(1):178-189. doi: 10.1007/s13311-017-0572-5..
• Monfrini M, Ravasi M, Maggioni D, Donzelli E, Tredici G, Cavaletti G, Scuteri A. Comparing the different response of PNS and CNS injured neurons to mesenchymal stem cell treatment. Mol Cell Neurosci. 2018 Jan;86:16-24. doi: 10.1016/j.mcn.2017.11.004. Epub 2017 Nov 6.

2017

• Alberti P. Chemotherapy-induced peripheral neurotoxicity – outcome measures: the issue. Expert Opin Drug Metab Toxicol. 2017 Mar;13(3):241-243. doi: 10.1080/17425255.2017.1258400.
• Argyriou AA, Bruna J, Genazzani AA, Cavaletti G. Chemotherapy-induced peripheral neurotoxicity: management informed by pharmacogenetics. Nat Rev Neurol. 2017 Aug;13(8):492-504. doi: 10.1038/nrneurol.2017.88.
• Avallone G, Pellegrino V, Roccabianca P, Lepri E, Crippa L, Beha G, De Tolla L, Sarli G. Tyrosine Kinase Receptor Expression in Canine Liposarcoma. Vet Pathol. 2017 Mar;54(2):212-217. doi: 10.1177/0300985816671379.
• Beretta S, Versace A, Carone D, Riva M, Dell’Era V, Cuccione E, Cai R, Monza L, Pirovano S, Padovano G, Stiro F, Presotto L, Paternò G, Rossi E, Giussani C, Sganzerla EP, Ferrarese C.  Cerebral collateral therapeutics in acute ischemic stroke: A randomized preclinical trial of four modulation strategies. J Cereb Blood Flow Metab. 2017 Oct;37(10):3344-3354. doi: 10.1177/0271678X16688705.
• Bruna J, Videla S, Argyriou AA, Velasco R, Villoria J, Santos C, Nadal C, Cavaletti G, Alberti P, Briani C, Kalofonos HP, Cortinovis D, Sust M, Vaqué A, Klein T, Plata-Salamán C. Efficacy of a Novel Sigma-1 Receptor Antagonist for Oxaliplatin-Induced Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Clinical Trial. Neurotherapeutics. 2017 Sep 18. doi: 10.1007/s13311-017-0572-5.
• Carrà G, Nicolini G, Lax A, Bartoli F, Castellano F, Chiorazzi A, Gamba G, Bava M, Crocamo C, Papagno C. Facial emotion recognition in schizophrenia: An exploratory study on the role of comorbid alcohol and substance use disorders and COMT Val158Met. Hum Psychopharmacol. 2017 Nov;32(6). doi: 10.1002/hup.2630. Epub 2017 Sep 15
• Cavaletti G, Marmiroli P. Pharmacotherapy options for managing chemotherapy-induced peripheral neurotoxicity. Expert Opin Pharmacother. 2017 Dec 15:1-9. doi: 10.1080/14656566.2017.1415326.
• Collina S, Rui M, Stotani S, Bignardi E, Rossi D, Curti D, Giordanetto F, Malacrida A, Scuteri A, Cavaletti G. Are sigma receptor modulators a weapon against multiple sclerosis disease? Future Med Chem. 2017 Nov;9(17):2029-2051. doi: 10.4155/fmc-2017-0122.
• Cuccione E, Versace A, Cho TH, Carone D, Berner LP, Ong E, Rousseau D, Cai R, Monza L, Ferrarese C, Sganzerla EP, Berthezène Y, Nighoghossian N, Wiart M, Beretta S, Chauveau F. Multi-site laser Doppler flowmetry for assessing collateral flow in experimental ischemic stroke: Validation of outcome prediction with acute MRI. J Cereb Blood Flow Metab. 2017 Jun;37(6):2159-2170. doi: 10.1177/0271678X16661567.
• Dal Magro R, Ornaghi F, Cambianica I, Beretta S, Re F, Musicanti C, Rigolio R, Donzelli E, Canta A, Ballarini E, Cavaletti G, Gasco P, Sancini G. ApoE-modified solid lipid nanoparticles: A feasible strategy to cross the blood-brain barrier. J Control Release. 2017 Mar 10;249:103-110. doi: 10.1016/j.jconrel.2017.01.039.
• Gandin V, Ceresa C, Esposito G, Indraccolo S, Porchia M, Tisato F, Santini C, Pellei M, Marzano C. Therapeutic potential of the phosphino Cu(I) complex (HydroCuP) in the treatment of solid tumors. Sci Rep. 2017 Oct 24;7(1):13936. doi: 10.1038/s41598-017-13698-1.
• Gastaldi M, Zardini E, Leante R, Ruggieri M, Costa G, Cocco E, De Luca G, Cataldo I, Biagioli T, Ballerini C, Castellazzi M, Fainardi E, Pettini P, Zaffaroni M, Giunti D, Capello E, Bernardi G, Ciusani E, Giannotta C, Nobile-Orazio E, Bazzigaluppi E, Passerini G, Bedin R, Sola P, Brivio R, Cavaletti G, Sala A, Bertolotto A, Desina G, Leone MA, Mariotto S, Ferrari S, Paternoster A, Giavarina D, Lolli F, Franciotta D. Cerebrospinal fluid analysis and the determination of oligoclonal bands. Neurol Sci. 2017 Oct;38(Suppl 2):217-224. doi: 10.1007/s10072-017-3034-2.
• Gewandter JS, Burke L, Cavaletti G, Dworkin RH, Gibbons C, Gover TD, Herrmann DN, Mcarthur JC, McDermott MP, Rappaport BA, Reeve BB, Russell JW, Smith AG, Smith SM, Turk DC, Vinik AI, Freeman R. Content validity of symptom-based measures for diabetic, chemotherapy, and HIV peripheral neuropathy. Muscle Nerve. 2017 Mar;55(3):366-372. doi: 10.1002/mus.25264.
• Gewandter JS, Freeman R, Kitt RA, Cavaletti G, Gauthier LR, McDermott MP, Mohile NA, Mohlie SG, Smith AG, Tejani MA, Turk DC, Dworkin RH. Chemotherapy-induced peripheral neuropathy clinical trials: Review and recommendations. Neurology. 2017 Aug 22;89(8):859-869. doi: 10.1212/WNL.0000000000004272.
• Griffith KA, Zhu S, Johantgen M, Kessler MD, Renn C, Beutler AS, Kanwar R, Ambulos N, Cavaletti G, Bruna J, Briani C, Argyriou AA, Kalofonos HP, Yerges-Armstrong LM, Dorsey SG. Oxaliplatin-Induced Peripheral Neuropathy and Identification of Unique Severity Groups in Colorectal Cancer. J Pain Symptom Manage. 2017 Nov;54(5):701-706.e1. doi: 10.1016/j.jpainsymman.2017.07.033.
• Kieffer JM, Postma TJ, van de Poll-Franse L, Mols F, Heimans JJ, Cavaletti G, Aaronson NK; CI-PeriNomS Group. Evaluation of the psychometric properties of the EORTC chemotherapy-induced peripheral neuropathy questionnaire (QLQ-CIPN20). Qual Life Res. 2017 Nov;26(11):2999-3010. doi: 10.1007/s11136-017-1626-1.
• Lavoie Smith EM, Haupt R, Kelly JP, Lee D, Kanzawa-Lee G, Knoerl R, Bridges C, Alberti P, Prasertsri N, Donohoe C. The Content Validity of a Chemotherapy-Induced Peripheral Neuropathy Patient-Reported Outcome Measure. Oncol Nurs Forum. 2017 Sep 1;44(5):580-588. doi: 10.1188/17.ONF.580-588.
• Manodoro S, Spelzini F, Cesana MC, Frigerio M, Maggioni D, Ceresa C, Penati C, Sicuri M, Fruscio R, Nicolini G, Milani R. Histologic and metabolic assessment in a cohort of patients with genital prolapse: preoperative stage and recurrence investigations. Minerva Ginecol. 2017 Jun;69(3):233-238. doi: 10.23736/S0026-4784.16.03977-0.
• Marmiroli P, Riva B, Pozzi E, Ballarini E, Lim D, Chiorazzi A, Meregalli C, Distasi C, Renn CL, Semperboni S, Morosi L, Ruffinatti FA, Zucchetti M, Dorsey SG, Cavaletti G, Genazzani A, Carozzi VA. Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: Phenotypic and genotypic insights. PLoS One. 2017 Oct 11;12(10):e0186250. doi: 10.1371/journal.pone.0186250. eCollection 2017.
• Marmiroli P, Scuteri A, Cornblath DR, Cavaletti G. Pain in chemotherapy-induced peripheral neurotoxicity. J Peripher Nerv Syst. 2017 Sep;22(3):156-161. doi: 10.1111/jns.12226.
• Melcangi RC, Santi D, Spezzano R, Grimoldi M, Tabacchi T, Fusco ML, Diviccaro S, Giatti S, Carrà G, Caruso D, Simoni M, Cavaletti G. Neuroactive steroid levels and psychiatric and andrological features in post-finasteride patients. J Steroid Biochem Mol Biol. 2017 Jul;171:229-235. doi: 10.1016/j.jsbmb.2017.04.003.
• Meroni R, Alberti P, Boria P, Giordano S, Cavaletti G. Distal pain and carpal tunnel syndrome diagnosis among cashiers: a longitudinal study. Int Arch Occup Environ Health. 2017 Nov;90(8):741-746. doi: 10.1007/s00420-017-1237-8. Epub 2017 Jun 20. Erratum in: Int Arch Occup Environ Health. 2017 Nov;90(8):747-750.
• Monfrini M, Donzelli E, Rodriguez-Menendez V, Ballarini E, Carozzi VA, Chiorazzi A, Meregalli C, Canta A, Oggioni N, Crippa L, Avezza F, Silvani S, Bonandrini B, Figliuzzi M, Remuzzi A, Porretta-Serapiglia C, Bianchi R, Lauria G, Tredici G, Cavaletti G, Scuteri A. Therapeutic potential of Mesenchymal Stem Cells for the treatment of diabetic peripheral neuropathy. Exp Neurol. 2017 Feb;288:75-84. doi: 10.1016/j.expneurol.2016.11.006.
• Parlanti P, Cappello V, Brun F, Tromba G, Rigolio R, Tonazzini I, Cecchini M, Piazza V, Gemmi M. Size and specimen-dependent strategy for x-ray micro-ct and tem correlative analysis of nervous system samples. Sci Rep. 2017 Jun 6;7(1):2858. doi: 10.1038/s41598-017-02998-1.
• Schültke E, Balosso J, Breslin T, Cavaletti G, Djonov V, Esteve F, Grotzer M, Hildebrandt G, Valdman A, Laissue J. Microbeam radiation therapy – grid therapy and beyond: a clinical perspective. Br J Radiol. 2017 Oct;90(1078):20170073. doi: 10.1259/bjr.20170073.
• Van Helleputte L, Kater M, Cook DP, Eykens C, Rossaert E, Haeck W, Jaspers T, Geens N, Vanden Berghe P, Gysemans C, Mathieu C, Robberecht W, Van Damme P, Cavaletti G, Jarpe M, Van Den Bosch L. Inhibition of histone deacetylase 6 (HDAC6) protects against vincristine-induced peripheral neuropathies and inhibits tumor growth. Neurobiol Dis. 2017 Nov 29;111:59-69. doi: 10.1016/j.nbd.2017.11.011.
• Wozniak KM, Vornov JJ, Wu Y, Liu Y, Carozzi VA, Rodriquez-Menendez V, Ballarini E, Alberti P, Pozzi E, Semperboni S, Cook BM, Littlefield BA, Nomoto K, Condon K, Eckley S, DesJardins C, Wilson L, Jordan MA, Feinstein SC, Cavaletti G, Polydefkis M, Slusher BS.Peripheral neuropathy induced by microtubule-targeted chemotherapies: insights into acute injury and long-term recovery. Cancer Res. 2017 Nov 30. pii: canres.1467.2017. doi: 10.1158/0008-5472.CAN-17-1467.

2016

• Alberti P, Parma M, Pioltelli P, Pogliani EM, Terruzzi E, Stasia A, Doni E, Cecchetti C, Cavaletti G. Severe, reversible nelarabine-induced neuropathy and myelopathy. J Peripher Nerv Syst. 2016 Sep; 21(3):154-6. doi: 10.1111/jns.12173.
• Avallone G, Roccabianca P, Crippa L, Lepri E, Brunetti B, Bernardini C, Forni M, Olandese A, Sarli G. Histological Classification and Immunohistochemical Evaluation of MDM2 and CDK4 Expression in Canine Liposarcoma. Vet Pathol. 2016 Jul; 53(4):773-80. doi: 10.1177/0300985815626573.
• Arosio A, Sala G, Rodriguez-Menendez V, Grana D, Gerardi F, Lunetta C, Ferrarese C, Tremolizzo L. MEF2D and MEF2C pathways disruption in sporadic and familial ALS patients. Mol Cell Neurosci. 2016 Jul; 74:10-7.  doi: 10.1016/j.mcn.2016.02.002.
• Bacigaluppi S, Donzelli E, De Cristofaro V, Bragazzi NL, D’Amico G, Scuteri A, Tredici G. Human endothelial progenitor cells rescue cortical neurons from oxygen-glucose deprivation induced death. Neurosci Lett. 2016 Sep 19; 631:50-5. doi: 10.1016/j.neulet.2016.08.014.
• Bentivegna A, Roversi G, Riva G, Paoletta L, Redaelli S, Miloso M, Tredici G, Dalprà L. The Effect of Culture on Human Bone Marrow Mesenchymal Stem Cells: Focus on DNA Methylation Profiles. Stem Cells Int. 2016; 2016:5656701. doi: 10.1155/2016/5656701.
• Caccianiga G, Cambini A, Donzelli E, Baldoni M, Rey G, Paiusco A. Effects of laser biostimulation on the epithelial tissue for keratinized layer differentiation: an in vitro study. J Biol Regul Homeost Agents. 2016 Apr-Jun; 30 (2 Suppl 1):99-105.
• Canta A, Chiorazzi A, Carozzi VA, Meregalli C, Oggioni N, Bossi M, Rodriguez-Menendez V, Avezza F, Crippa L, Lombardi R, de Vito G, Piazza V, Cavaletti G, Marmiroli P. Age-related changes in the function and structure of the peripheral sensory pathway in mice. Neurobiol Aging. 2016 Sep; 45:136-148. doi: 10.1016/j.neurobiolaging.2016.05.014.
• Malacrida A, Maggioni D, Cassetti A, Nicolini G, Cavaletti G, Miloso M. Antitumoral Effect of Hibiscus sabdariffa on Human Squamous Cell Carcinoma and Multiple Myeloma Cells. Nutr Cancer. 2016 Oct; 68(7):1161-70. doi: 10.1080/01635581.2016.1208830.
• Marra A, Rossi D, Pignataro L, Bigogno C, Canta A, Oggioni N, Malacrida A, Corbo M, Cavaletti G, Peviani M, Curti D, Dondio G, Collina S. Toward the identification of neuroprotective agents: g-scale synthesis, pharmacokinetic evaluation and CNS distribution of (R)-RC-33, a promising SIGMA1 receptor agonist. Future Med Chem. 2016; 8(3):287-95. doi: 10.4155/fmc.15.191.
• Mezzapelle R, Rrapaj E, Gatti E, Ceriotti C, Marchis FD, Preti A, Spinelli AE, Perani L, Venturini M, Valtorta S, Moresco RM, Pecciarini L, Doglioni C, Frenquelli M, Crippa L, Recordati C, Scanziani E, de Vries H, Berns A, Frapolli R, Boldorini R, D’Incalci M, Bianchi ME, Crippa MP. Human malignant mesothelioma is recapitulated in immunocompetent BALB/c mice injected with murine AB cells. Sci Rep. 2016 Mar 10;6:22850. doi: 10.1038/srep22850.
• Monfrini M, Donzelli E, Rodriguez-Menendez V, Ballarini E, Carozzi VA, Chiorazzi A, Meregalli C, Canta A, Oggioni N, Crippa L, Avezza F, Silvani S, Bonandrini B, Figliuzzi M, Remuzzi A, Porretta-Serapiglia C, Bianchi R, Lauria G, Tredici G, Cavaletti G, Scuteri A. Therapeutic potential of Mesenchymal Stem Cells for the treatment of diabetic peripheral neuropathy. Exp Neurol. 2017 Feb; 288:75-84. doi: 10.1016/j.expneurol.2016.11.006.
• Pachman DR, Qin R, Seisler D, Smith EM, Kaggal S, Novotny P, Ruddy KJ, Lafky JM, Ta LE, Beutler AS, Wagner-Johnston ND, Staff NP, Grothey A, Dougherty PM, Cavaletti G, Loprinzi CL. Comparison of oxaliplatin and paclitaxel-induced neuropathy (Alliance A151505). Support Care Cancer. 2016 Dec; 24(12):5059-5068.
• Redaelli S, Ceccon M, Antolini L, Rigolio R, Pirola A, Peronaci M, Gambacorti-Passerini C, Mologni L. Synergistic activity of ALK and mTOR inhibitors for the treatment of NPM-ALK positive lymphoma. Oncotarget. 2016 Nov 8;7(45):72886-72897. doi: 10.18632/oncotarget.12128
• Rigolio R., Ballarini E., Grimoldi M., Gardinetti M., Di Sante G. Multiple Sclerosis Drug Therapy: from the Classical Pharmaceutical down to Cellular and Molecular Approach. 2016 BENTHAM e-Books series – Frontiers in Clinical Drug Research – CNS and Neurological Disorders, Vol. 4, 3-113, 2016. ISBN(PRINT): 978-1-68108-296-7, eISBN: 978-1-68108-295-0.
• Roccabianca P, Avallone G, Rodriguez A, Crippa L, Lepri E, Giudice C, Caniatti M, Moore PF, Affolter VK. Cutaneous Lymphoma at Injection Sites: Pathological, Immunophenotypical, and Molecular Characterization in 17 Cats. Vet Pathol. 2016 Jul; 53(4):823-32. doi: 10.1177/0300985815623620.
• Scuteri A, Cavaletti G. How can neuroplasticity be utilized to improve neuropathy symptoms? Expert Rev Neurother. 2016 Nov; 16(11):1235-1236.
• Sprowl JA, Ong SS, Gibson AA, Hu S, Du G, Lin W, Li L, Bharill S, Ness RA, Stecula A, Offer SM, Diasio RB, Nies AT, Schwab M, Cavaletti G, Schlatter E, Ciarimboli G, Schellens JH, Isacoff EY, Sali A, Chen T, Baker SD, Sparreboom A, Pabla N. A phosphotyrosine switch regulates organic cation transporters. Nat Commun. 2016 Mar 16;7:10880. doi: 10.1038/ncomms10880.
• Zhu J, Carozzi VA, Reed N, Mi R, Marmiroli P, Cavaletti G, Hoke A. Ethoxyquin provides neuroprotection against cisplatin-induced neurotoxicity. Sci Rep. 2016 Jun 28; 6:28861. doi: 10.1038/srep28861.

2015

• Avan A, Postma TJ, Ceresa C, Avan A, Cavaletti G, Giovannetti E, Peters GJ. Platinum-induced neurotoxicity and preventive strategies: past, present, and future. Oncologist. 2015 Apr;20(4):411-32. doi: 10.1634/theoncologist.2014-0044.
• Beretta S, Cuccione E, Versace A, Carone D, Riva M, Padovano G, Dell’Era V, Cai R, Monza L, Presotto L, Rousseau D, Chauveau F, Paternò G, Pappadà GB, Giussani C, Sganzerla EP, Ferrarese C. Cerebral collateral flow defines topography and evolution of molecular penumbra in experimental ischemic stroke. Neurobiol Dis. 2015 Feb;74:305-13. doi: 10.1016/j.nbd.2014.11.019.
• Binda D, Cavaletti G, Cornblath DR, Merkies IS; CI-PeriNomS study group. Rasch-Transformed Total Neuropathy Score clinical version (RT-TNSc(©) ) in patients with chemotherapy-induced peripheral neuropathy. J Peripher Nerv Syst. 2015 Sep;20(3):328-32. doi: 10.1111/jns.12140.
• Canta A, Pozzi E, Carozzi VA. Mitochondrial Dysfunction in Chemotherapy-Induced Peripheral Neuropathy (CIPN). Toxics. 2015 Jun 5;3(2):198-223. doi: 10.3390/toxics3020198.
• Carone D, Librizzi L, Cattalini A, Sala G, Conti E, Cuccione E, Versace A, Cai R, Monza L, de Curtis M, Ferrarese C, Beretta S. Pravastatin acute neuroprotective effects depend on blood brain barrier integrity in experimental cerebral ischemia. Brain Res. 2015 Jul 30;1615:31-41. doi: 10.1016/j.brainres.2015.04.025.
• Carozzi VA, Canta A, Chiorazzi A. Chemotherapy-induced peripheral neuropathy: What do we know about mechanisms? Neurosci Lett. 2015 Jun 2;596:90-107. doi: 10.1016/j.neulet.2014.10.014. Erratum in: Neurosci Lett. 2015 Jun 2;596():108.
• Carozzi VA, Chiorazzi A, Canta A, Meregalli C, Oggioni N, Cavaletti G, Marmiroli P. Chemotherapy-induced peripheral neurotoxicity in immune-deficient mice: new useful ready-to-use animal models. Exp Neurol. 2015 Feb;264:92-102. doi: 10.1016/j.expneurol.2014.11.002.
• Caruso D, Abbiati F, Giatti S, Romano S, Fusco L, Cavaletti G, Melcangi RC. Patients treated for male pattern hair with finasteride show, after discontinuation of the drug, altered levels of neuroactive steroids in cerebrospinal fluid and plasma. J Steroid Biochem Mol Biol. 2015 Feb;146:74-9. doi: 10.1016/j.jsbmb.2014.03.012.
• Cavaletti G, Alberti P, Marmiroli P. Chemotherapy-induced peripheral neurotoxicity in cancer survivors: an underdiagnosed clinical entity? Am Soc Clin Oncol Educ Book. 2015:e553-60. doi: 10.14694/EdBook_AM.2015.35.e553.
• Cavaletti G, Marmiroli P. Chemotherapy-induced peripheral neurotoxicity. Curr Opin Neurol. 2015 Oct;28(5):500-7. doi: 10.1097/WCO.0000000000000234.
• Cermenati G, Audano M, Giatti S, Carozzi V, Porretta-Serapiglia C, Pettinato E, Ferri C, D’Antonio M, De Fabiani E, Crestani M, Scurati S, Saez E, Azcoitia I, Cavaletti G, Garcia-Segura LM, Melcangi RC, Caruso D, Mitro N. Lack of sterol regulatory element binding factor-1c imposes glial Fatty Acid utilization leading to peripheral neuropathy. Cell Metab. 2015 Apr 7;21(4):571-83. doi: 10.1016/j.cmet.2015.02.016.
• Chiorazzi A, Semperboni S, Marmiroli P. Current View in Platinum Drug Mechanisms of Peripheral Neurotoxicity. Toxics. 2015 Aug 7;3(3):304-321. doi: 10.3390/toxics3030304.
• De Vito G, Canta A, Marmiroli P, Piazza V. A large-field polarisation-resolved laser scanning microscope: applications to CARS imaging. J Microsc. 2015 Nov;260(2):194-9. doi: 10.1111/jmi.12282.
• Giatti S, Rigolio R, Romano S, Mitro N, Viviani B, Cavaletti G, Caruso D, Garcia-Segura LM, Melcangi RC. Dihydrotestosterone as a Protective Agent in Chronic Experimental Autoimmune Encephalomyelitis. Neuroendocrinology. 2015;101(4):296-308. doi: 10.1159/000381064.
• Maggioni D, Monfrini M, Ravasi M, Tredici G, Scuteri A. Neurobasal medium toxicity on mature cortical neurons. Neuroreport. 2015 Apr 15;26(6):320-4. doi: 10.1097/WNR.0000000000000343.
• Marmiroli P, Cavaletti G, Carozzi V, Riva B, Lim D, Genazzani AA. Calcium-related neurotoxicity of oxaliplatin: understanding the mechanisms to drive therapy. Curr Med Chem. 2015;22(32):3682-94.
• Marmiroli P, Cavaletti G. Drugs for the treatment of peripheral neuropathies. Expert Opin Pharmacother. 2016;17(3):381-94. doi: 10.1517/14656566.2016.1120719. .
• Meregalli C, Carozzi VA, Sala B, Chiorazzi A, Canta A, Oggioni N, Rodriguez-Menendez V, Ballarini E, Ceresa C, Nicolini G, Crippa L, Orciani M, Cavaletti G, Marmiroli P. Bortezomib-induced peripheral neurotoxicity in human multiple myeloma-bearing mice. J Biol Regul Homeost Agents. 2015 Jan-Mar;29(1):115-24.
• Meregalli C. An Overview of Bortezomib-Induced Neurotoxicity. Toxics. 2015 Jul 27;3(3):294-303. doi: 10.3390/toxics3030294.
• Mitro N, Cermenati G, Audano M, Giatti S, D’Antonio M, Fabiani ED, Crestani M, Saez E, Azcoitia I, Cavaletti G, Garcia-Segura LM, Melcangi RC, Caruso D. The lipogenic regulator Sterol Regulatory Element Binding Factor-1c is required to maintain peripheral nerve structure and function. Springerplus. 2015 Jun 12;4(Suppl 1):L45. doi: 10.1186/2193-1801-4-S1-L45. eCollection 2015.
• Nicolini G, Monfrini M, Scuteri A. Axonal Transport Impairment in Chemotherapy-Induced Peripheral Neuropathy. Toxics. 2015 Aug 7;3(3):322-341. doi: 10.3390/toxics3030322. Review.
• Nobile-Orazio E, Cocito D, Jann S, Uncini A, Messina P, Antonini G, Fazio R, Gallia F, Schenone A, Francia A, Pareyson D, Santoro L, Tamburin S, Cavaletti G, Giannini F, Sabatelli M, Beghi E; IMC Trial Group. Frequency and time to relapse after discontinuing 6-month therapy with IVIg or pulsed methylprednisolone in CIDP. J Neurol Neurosurg Psychiatry. 2015 Jul;86(7):729-34. doi: 10.1136/jnnp-2013-307515.
• Othman A, Bianchi R, Alecu I, Wei Y, Porretta-Serapiglia C, Lombardi R, Chiorazzi A, Meregalli C, Oggioni N, Cavaletti G, Lauria G, von Eckardstein A, Hornemann T. Lowering plasma 1-deoxysphingolipids improves neuropathy in diabetic rats. Diabetes. 2015 Mar;64(3):1035-45. doi: 10.2337/db14-1325.
• Redaelli S, Perini P, Ceccon M, Piazza R, Rigolio R, Mauri M, Boschelli F, Giannoudis A, Gambacorti-Passerini C. In vitro and in vivo identification of ABCB1 as an efflux transporter of bosutinib.J Hematol Oncol. 2015 Jul 7;8:81. doi: 10.1186/s13045-015-0179-4.
• Scuteri A, Donzelli E, Rigolio R, Ballarini E, Monfrini M, Crippa L, Chiorazzi A, Carozzi V, Meregalli C, Canta A, Oggioni N, Tredici G,Cavaletti G. Therapeutic Administration of Mesenchymal Stem Cells Abrogates the Relapse Phase in Chronic Relapsing-Remitting EAE. J Stem Cell Res Ther 2015 Jan 5:262. doi:10.4172/2157-7633.1000262
• Scuteri A, Ravasi M, Monfrini M, Milano A, D’Amico G, Miloso M, Tredici G. Human Mesenchymal Stem Cells Protect Dorsal Root Ganglia from the Neurotoxic Effect of Cisplatin. Anticancer Res. 2015 Oct;35(10):5383-9.
• Spelzini F, Manodoro S, Frigerio M, Nicolini G, Maggioni D, Donzelli E, Altomare L, Farè S, Veneziano F, Avezza F, Tredici G, Milani R. Stem cell augmented mesh materials: an in vitro and in vivo study. Int Urogynecol J. 2015 May;26(5):675-83. doi: 10.1007/s00192-014-2570-z.
• Tambalo S*, Peruzzotti-Jametti L*, Rigolio R*, Fiorini S, Bontempi P, Mallucci G, Balzarotti B, Marmiroli P, Sbarbati A, Cavaletti G, Pluchino S, Marzola P. Functional Magnetic Resonance Imaging of Rats with Experimental Autoimmune Encephalomyelitis Reveals Brain Cortex Remodeling. J Neurosci. 2015 Jul 8;35(27):10088-100. doi: 10.1523/JNEUROSCI.0540-15.2015. *co-authorship
• Terrazzino S, Argyriou AA, Cargnin S, Antonacopoulou AG, Briani C, Bruna J, Velasco R, Alberti P, Campagnolo M, Lonardi S, Cortinovis D, Cazzaniga M, Santos C, Kalofonos HP, Canonico PL, Genazzani AA, Cavaletti G. Genetic determinants of chronic oxaliplatin-induced peripheral neurotoxicity: a genome-wide study replication and meta-analysis. J Peripher Nerv Syst. 2015 Mar;20(1):15-23. doi: 10.1111/jns.12110.